Company intelligence / Profile preview

g.tec medical engineering

Schiedlberg, Upper Austria, Austriagtec.at ↗

Ownership: Private
Development stage: Commercial

Overview

g.tec’s recoveriX BCI neurorehabilitation technology has demonstrated clinical benefit in improving motor function in stroke and multiple sclerosis patients by leveraging real-time feedback to induce neuroplasticity. The company’s products are CE-certified and FDA-cleared for use in hospitals and rehab centers.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (brain-computer interface and neurostimulation devices)
Industry: Physiological Monitoring

Partnerships

Collaborations with European Union research consortia and academic partners across Europe/Japan/US

Beyond the preview

Go deeper on g.tec medical engineering.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on g.tec medical engineering.

Explore the full profile